|
|
|
|
|
by graeme
1857 days ago
|
|
SARS-COV-1 also used ACE2 receptors. In fact your article specifically discusses that, and suggests there was potential to use SARS-COV-1 vaccine development to create SARS-COV-2 vaccines. The ACE2 receptor affinity is not novel. |
|
https://www.nature.com/articles/s41392-020-0184-0